New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - imiglucerase 212 u (biological product from recombinant cho cells) - powder for infusion - 40 u/ml - active: imiglucerase 212 u (biological product from recombinant cho cells) excipient: citric acid monohydrate mannitol nitrogen polysorbate 80 sodium citrate dihydrate

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - imiglucerase 400 u (per 10 ml -biological product from recombinant cho cells);   - powder for infusion - 40 u/ml - active: imiglucerase 400 u (per 10 ml -biological product from recombinant cho cells)   excipient: citric acid monohydrate mannitol nitrogen polysorbate 80 sodium citrate dihydrate - cerezyme is indicated for long - term enzyme replacement therapy for patients with a confirmed diagnosis of non-neuronopathic (type 1) or chronic neuronopathic (type 3) gaucher disease who exhibit clinically significant non-neurological manifestations of the disease. the non-neurological manifestations of gaucher disease include one or more of the following conditions: a) anaemia; b) thrombocytopenia; c) bone disease; d) hepatomegaly or splenomegaly.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - imiglucerase, quantity: 10 ml (equivalent: imiglucerase, qty 400 u) - injection, powder for - excipient ingredients: citric acid monohydrate; nitrogen; polysorbate 80; sodium citrate dihydrate; mannitol - cerezyme (imiglucerase) is indicated for long-term enzyme replacement therapy for patients with a confirmed diagnosis of non-neuronopathic (type 1) or chronic neuronopathic (type 3) gaucher disease who exhibit clinically significant non-neurological manifestations of the disease. the non-neurological manifestations of gaucher disease include one or more of the following conditions: a) anaemia; - b) thrombocytopenia; - c) bone disease; - d) hepatomegaly or splenomegaly.

Australia - English - Department of Health (Therapeutic Goods Administration)

genzyme australasia pty ltd - imiglucerase -

Canada - English - Health Canada

apotex inc - metoclopramide hydrochloride - tablet - 5mg - metoclopramide hydrochloride 5mg - prokinetic agents

Canada - English - Health Canada

apotex inc - metoclopramide hydrochloride - tablet - 10mg - metoclopramide hydrochloride 10mg - prokinetic agents

Canada - English - Health Canada

sanofi genzyme, a division of sanofi-aventis canada inc - imiglucerase - powder for solution - 200unit - imiglucerase 200unit - enzymes

Canada - English - Health Canada

pharmascience inc - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics

Canada - English - Health Canada

pharmascience inc - clozapine - tablet - 100mg - clozapine 100mg - atypical antipsychotics

Canada - English - Health Canada

sanofi genzyme, a division of sanofi-aventis canada inc - imiglucerase - powder for solution - 400unit - imiglucerase 400unit - enzymes